Medicare Enrolled
Dr. James Perruquet, M.D.
Rheumatology · New Bern, NC
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Perruquet from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Perruquet?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Perruquet
Dr. James Perruquet is a rheumatology specialist in New Bern, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Perruquet performed 11,527 Medicare services across 2,977 unique beneficiaries.
Between the years covered by Open Payments, Dr. Perruquet received a total of $6,049 from 67 pharmaceutical and/or device companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Perruquet is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 44% volume in NC
$6,049 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,527
Medicare services
Top 44% in NC for rheumatology
2,977
Unique beneficiaries
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~576 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,275 | $34 | $65 |
| Denosumab injection (Prolia/Xgeva) | 2,642 | $18 | $35 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
1,364 | $35 | $175 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
540 | $28 | $76 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
404 | $83 | $245 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
214 | $3 | $10 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
190 | $8 | $12 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
182 | $8 | $24 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
181 | $10 | $32 |
| Bone density scan (DEXA) of hip, pelvis, and spine This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures. |
114 | $48 | $200 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
104 | $89 | $280 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
80 | $9 | $40 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
67 | $1 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
53 | $58 | $172 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
33 | $6 | $20 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
23 | $89 | $307 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
21 | $18 | $54 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
15 | $29 | $100 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
13 | $4 | $15 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
12 | $5 | $16 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
46.7% high complexity
24.2% medium
29.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,049
Total received (2018-2024)
Avg $864/year across 7 years
Top 38% in NC for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
371
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,049 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$916
2023
$525
2022
$817
2021
$660
2020
$235
2019
$1,176
2018
$1,719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$355
Radius Health, Inc.
$90
Amgen Inc.
$78
Lilly USA, LLC
$74
E.R. Squibb & Sons, L.L.C.
$51
Lundbeck LLC
$31
Fresenius Kabi USA, LLC
$25
Merck Sharp & Dohme LLC
$23
SCILEX PHARMACEUTICALS INC.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$20
Grifols USA, LLC
$17
Regeneron Healthcare Solutions, Inc.
$17
AstraZeneca Pharmaceuticals LP
$16
Biogen, Inc.
$15
VERTEX PHARMACEUTICALS INCORPORATED
$15
Janssen Biotech, Inc.
$15
PFIZER INC.
$15
Ardelyx, Inc.
$14
Top 3 companies account for 57.0% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$757
AbbVie, Inc.
$565
ABBVIE INC.
$503
Grifols USA, LLC
$456
PFIZER INC.
$348
Janssen Biotech, Inc.
$319
Genentech USA, Inc.
$221
Regeneron Healthcare Solutions, Inc.
$215
Lilly USA, LLC
$149
Actelion Pharmaceuticals US, Inc.
$146
Akcea Therapeutics, Inc.
$144
Radius Health, Inc.
$140
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
AstraZeneca Pharmaceuticals LP
$117
Sunovion Pharmaceuticals Inc.
$112
GlaxoSmithKline, LLC.
$108
Mallinckrodt LLC
$107
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$80
Janssen Pharmaceuticals, Inc
$77
E.R. Squibb & Sons, L.L.C.
$75
Novartis Pharmaceuticals Corporation
$73
AbbVie Inc.
$68
Lundbeck LLC
$64
Amarin Pharma Inc.
$55
Novo Nordisk Inc
$52
CSL Behring
$50
Takeda Pharmaceuticals U.S.A., Inc.
$47
Alexion Pharmaceuticals, Inc.
$47
Daiichi Sankyo Inc.
$42
SANOFI-AVENTIS U.S. LLC
$41
BANNER LIFE SCIENCES, LLC
$35
EMD Serono, Inc.
$34
Medtronic, Inc.
$33
Horizon Pharma plc
$30
PORTOLA PHARMACEUTICALS, INC.
$29
Horizon Therapeutics plc
$28
ARGENX US, INC.
$27
Celgene Corporation
$25
GENZYME CORPORATION
$25
Fresenius Kabi USA, LLC
$25
Corium, LLC
$24
Merck Sharp & Dohme LLC
$23
SCILEX PHARMACEUTICALS INC.
$23
Allergan Inc.
$22
RECORDATI_RARE_DISEASES_INC.
$20
Eisai Inc.
$19
Organon LLC
$19
Ironwood Pharmaceuticals, Inc
$17
Sandoz Inc.
$17
Teva Pharmaceuticals USA, Inc.
$17
Vertical Pharmaceuticals, LLC
$16
Mallinckrodt Enterprises LLC
$16
Biogen, Inc.
$15
VERTEX PHARMACEUTICALS INCORPORATED
$15
Merck Sharp & Dohme Corporation
$15
MITSUBISHI TANABE PHARMA AMERICA, INC.
$15
Biohaven Pharmaceutical Holding Company Ltd.
$14
Allergan, Inc.
$14
Ardelyx, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Insmed, Inc.
$14
Biohaven Pharmaceuticals, Inc.
$14
United Therapeutics Corporation
$13
JAZZ PHARMACEUTICALS INC.
$13
Amneal Pharmaceuticals LLC
$12
Shire North American Group Inc
$12
Jazz Pharmaceuticals Inc.
$12
Top 3 companies account for 30.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADLARITY · AJOVY · ANORO · Actemra · Aimovig · Arikayce · BAFIERTAM · BENLYSTA · BEVYXXA · BOTOX · BYDUREON · CHANTIX · COSENTYX · CYCLOSET · DUPIXENT · EVENITY · Enbrel · FARXIGA · FORTEO · GAMMAGARD · GARDASIL 9 · GLASSIA · HUMIRA · HYRIMOZ · Hizentra · Horizant · Humira · IBSRELA · INJECTAFER · INTELLIS ADAPTIVESTIM · KEVZARA SARILUMAB INJECTION · KEYTRUDA · KRYSTEXXA · LEQEMBI · LINZESS · LONHALA MAGNAIR · Leqembi · MAVENCLAD · MOUNJARO · NURTEC ODT · OFEV · OPSUMIT · ORENCIA · OSMOLEX ER · Otezla · PENNSAID · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolastin-C · Prolastin-C Liquid · Prolia · RADICAVA · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Repatha · Rinvoq · Rituxan · SAPHNELO · SHINGRIX · SIGNIFOR LAR · SIMPONI · SIMPONI ARIA · SKYRIZI · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Saxenda · TALTZ · TEGSEDI · TEZSPIRE · TRELEGY ELLIPTA · TREMFYA · TYVASO · TZIELD · Tymlos · UBRELVY · ULTOMIRIS · UNITHROID · UTIBRON NEOHALER · Utibron · VYEPTI · VYVGART · Vascepa · XARELTO · XELJANZ · XIFAXAN · Xembify · Xolair · Xyrem · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Rheumatologists within 10 mi
4
Per 100K population
4.0
County median income
$64,635
Nearest hospital
CAROLINA EAST MEDICAL CENTER
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Perruquet is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Perruquet experienced with abatacept infusion (orencia)?
Based on Medicare claims data, Dr. Perruquet performed 5,275 abatacept infusion (orencia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Perruquet receive payments from pharmaceutical companies?
Yes. Dr. Perruquet received a total of $6,049 from 67 companies across 371 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Perruquet's costs compare to other rheumatologists in New Bern?
Dr. Perruquet's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Perruquet) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in New Bern
Browse rheumatologists in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in NC
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in NC
Which NC rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology